3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
1223
Neoplasms
1028
Carcinoma, Non-Small-Cell Lung
747
Prostatic Neoplasms
693
Colorectal Neoplasms
591
Lung Neoplasms
576
Leukemia, Myeloid, Acute
396
Pancreatic Neoplasms
395
Neoplasm Metastasis
389
Ovarian Neoplasms
369
Multiple Myeloma
369
Stomach Neoplasms
318
Carcinoma, Hepatocellular
303
Melanoma
283
Brain Neoplasms
281
Recurrence
274
Squamous Cell Carcinoma of Head and Neck
266
Head and Neck Neoplasms
239
Glioblastoma
235
Endometrial Neoplasms
232
Triple Negative Breast Neoplasms
230
Lymphoma
223
Precursor Cell Lymphoblastic Leukemia-Lymphoma
222
Uterine Cervical Neoplasms
221
Sarcoma
202
Hematologic Neoplasms
202
Urinary Bladder Neoplasms
198
Esophageal Neoplasms
190
Carcinoma, Renal Cell
188
Lymphoma, Non-Hodgkin
176
Interventions
ribociclib
1
palbociclib
1
abemaciclib
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
ER+ HER2- Advanced Breast Cancer
×
1 year
×
Clear all
NCT06188520
2026-05-11
CYCAD-1
AstraZeneca
Phase 1/2
Recruiting
564 enrolled